| ARCHETYPE ID | openEHR-EHR-OBSERVATION.atria_bleeding_risk.v0 |
|---|---|
| Concept | ATRIA bleeding risk score |
| Description | An assessment score used to predict the risk of warfarin-associated haemorrhage and guide physician decision-making regarding warfarin use in atrial fibrillation. |
| Use | Use to record the results for each component parameter and their total sum for the ATRIA bleeding risk score. |
| Misuse | Do not use if the patient does not have atrial fibrillation. |
| Purpose | To record the results for each component parameter and their total sum for the ATRIA bleeding risk score. |
| References | Fang MC, Go AS, Chang Y, Borowsky LH, Pomernacki NK, Udaltsova N, Singer DE. A new risk scheme to predict warfarin-associated hemorrhage: The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study. Journal of the American College of Cardiology. 2011 Jul 19;58(4):395-401. Apostolakis S, Lane DA, Guo Y, Buller H, Lip GY. Performance of the HEMORR 2 HAGES, ATRIA, and HAS-BLED Bleeding Risk–Prediction Scores in Patients With Atrial Fibrillation Undergoing Anticoagulation: The AMADEUS (Evaluating the Use of SR34006 Compared to Warfarin or Acenocoumarol in Patients With Atrial Fibrillation) Study. Journal of the American College of Cardiology. 2012 Aug 28;60(9):861-7. Roldán V, Marín F, Fernández H, Manzano-Fernandez S, Gallego P, Valdés M, Vicente V, Lip GY. Predictive value of the HAS-BLED and ATRIA bleeding scores for the risk of serious bleeding in a “real-world” population with atrial fibrillation receiving anticoagulant therapy. CHEST Journal. 2013 Jan 1;143(1):179-84. |
| Copyright | © Cambio Healthcare Systems, openEHR Foundation |
| Authors | Author name: Eneimi Allwell-Brown Organisation: Cambio Healthcare Systems Email: models@cambiocds.com Date originally authored: 2017-02-13 |
| Other Details Language | Author name: Eneimi Allwell-Brown Organisation: Cambio Healthcare Systems Email: models@cambiocds.com Date originally authored: 2017-02-13 |
| Other Details (Language Independent) |
|
| Keywords | anticoagulation, atrial fibrillation, warfarin, major hemorrhage, hemorrhage risk, cardiology |
| Lifecycle | in_development |
| UID | 362f6dc8-d03a-4efe-91db-5f5c83affb54 |
| Language used | en |
| Citeable Identifier | 1246.145.2808 |
| Revision Number | 0.0.1-alpha |
| protocol | |
| Extension | Extension: Additional information required to capture local content or to align with other reference models/formalisms. For example: local information requirements or additional metadata to align with FHIR or CIMI equivalents. Include: All not explicitly excluded archetypes |
| data | |
| Anemia | Anemia: Presence of hemoglobin concentration <13 g/dl (male) or <12 g/dl (female). 0: No [*] 3: Yes [*] |
| Severe renal disease | Severe renal disease: Presence of estimated glomerular filtration rate (eGFR) <30 ml/min or dialysis-dependent. 0: No [*] 3: Yes [*] |
| Age ≥75 years | Age ≥75 years: Individual is 75 years or older. 0: No [*] 2: Yes [*] |
| Prior hemorrhage diagnosis | Prior hemorrhage diagnosis: Any prior hemorrhage diagnosis (internal or external hemorrhage). 0: No [*] 1: Yes [*] |
| History of hypertension | History of hypertension: History of diagnosed hypertension. 0: No [*] 1: Yes [*] |
| Total score | Total score: Sum of points assigned for each of the component parameters. min: >=0; max: <=10 |
| events | |
| Any point in time event | Any point in time event: Default, unspecified point in time event which may be explicitly defined in a template or at run-time. |
| Other contributors | Heather Leslie, Atomica Informatics, Australia |
| Translators |